ENDRA Life Sciences Inc. (NDRA) delivered a return of 81.21% over the past year. Since NDRA does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in ENDRA Life Sciences Inc. one year ago would be worth $18,121 today, representing a gain of $8,121.

ENDRA Life Sciences Inc. (NDRA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For NDRA, the total return equals the price-only return.

Yes, ENDRA Life Sciences Inc. (NDRA) outperformed the S&P 500 by 60.37 percentage points over the past year. NDRA delivered a total return of 81.21%, compared to the S&P 500's 20.84%. This 60.37pp alpha means investors in NDRA earned more than a passive S&P 500 index fund.

ENDRA Life Sciences Inc. (NDRA) experienced a maximum drawdown of -63.12% over the past year, declining from its peak on 2025-07-09 to its trough on 2026-03-19. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are ENDRA Life Sciences Inc. (NDRA)'s long-term returns with dividends reinvested. Over 10 years, the total return is -100.0% (-63.2% CAGR) — $10,000 would have grown to $0. Over 20 years: -100.0% total return (-39.3% CAGR) — $10,000 → $0. Over 30 years: -100.0% total return (-28.3% CAGR) — $10,000 → $0. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

ENDRA Life Sciences Inc.'s best calendar year was 2017 with a total return of 24.6%. Its worst year was 2024 with a total return of -99.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 124.4 percentage points.